Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays-An update from the Canadian society of clinical chemists (CSCC)

Peter A. Kavsak, Lynn C. Allen, Fred S. Apple, Ronald A. Booth, Pak Cheung Chan, Edgard Delvin, Albert Fraser, Lei Fu, Douglas Gornall, Christine Collier, Stephen Hill, Barry Hoffman, Yun Huang, Joël Lavoie, Amy Lou, Andre Mattman, Matthew McQueen, Qing H. Meng, Curtis Oleschuk, Morris PudekEdward Randell, Kun Young Sohn, Laurel Thorlacius, Paul M. Yip, Nagib Dahdah, P. J. Devereaux, Sukhbinder Dhesy-Thind, Sebastien J. Hotte, Andrew Worster

Producción científica: Contribución a una revistaEditorialrevisión exhaustiva

30 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)1273-1277
Número de páginas5
PublicaciónClinical Biochemistry
Volumen44
N.º16
DOI
EstadoPublished - nov. 2011

Nota bibliográfica

Funding Information:
Dr. Kavsak has received speaker fees and/or grant support from the following diagnostic companies that manufacture cardiac troponin assays: Abbott, Beckman Coulter, Ortho Clinical Diagnostics, Randox, Roche. Dr. Apple has been a paid consultant for Abbott, Ortho Clinical Diagnostics, Beckman Coulter and Instrumentation Laboratories; has served on advisory boards for Ortho Clinical Diagnostics, Alere/Biosite and Instrumentation Laboratories; has received research grant funding from Abbott Diagnostics, Alere/Biosite, Ortho Clinical Diagnostics, Response Biomedical, Siemens, Radiometer, Singulex, BioRad, Becton Dickinson, BRAHMS, Mitsubishi and Roche. Dr. Yip has received consulting fees from Abbott. Dr. Worster has received an honorarium for serving on an advisory board and served as an unpaid investigator for Roche Diagnostics.

ASJC Scopus Subject Areas

  • Clinical Biochemistry

PubMed: MeSH publication types

  • Editorial

Citar esto